HHS, FDA Want to Slash Health Care Rules in 10-to-1 Deregulation Plan
The agencies are asking stakeholders to weigh in on a sweeping deregulatory initiative that will eliminate 10 regulations for every one introduced.
The agencies are asking stakeholders to weigh in on a sweeping deregulatory initiative that will eliminate 10 regulations for every one introduced.
New framework calls for clear regulatory pathways, data access reform, and reimbursement strategies to advance AI-enabled medical devices.
The shortage is expected to impact patient care, prompting the FDA to recommend conservation strategies for health care providers.
The agencies are asking stakeholders to weigh in on a sweeping deregulatory initiative that will eliminate 10 regulations for every one introduced.
FDA has recognized four AAMI sterilization documents in its Consensus Standards Database, including updated guidance on ethylene oxide usage.
Read MorePhilips’ cardiac telemetry Monitoring Service Application did not route some ECG events from July 2022 to July 2024 for cardiology review.
Read MoreThe FDA published new draft guidance targeting pulse oximeter accuracy disparities across diverse skin tones.
Read MoreThe FDA released draft guidance outlining a comprehensive framework for AI-enabled devices throughout their life cycle.
Read MoreBaxter is recalling certain Solution Sets with Duo-Vent Spikes due to an assembly issue that led to inverted slide clamps.
Read MoreThe Inogen Simeox 200 Airway Clearance Device aids bronchial drainage in patients with chronic respiratory conditions using high-frequency oscillatory vibrations and intermittent negative pressure.
Read MoreInterlynk’s SBOM Automation Platform helps healthcare organizations manage software risks, maintain transparency, and meet FDA guidelines.